IB
ALXN

Intrust Bank’s Alexion Pharmaceuticals ALXN Stock Holding History

Intrust Bank’s Portfolio ALXN Stock Details ALXN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-1,977
Closed -$363K – 392
2021
Q2 		$363K Sell
1,977
-348
-15% -$59.7K 0.05% 278
2021
Q1 		$355K Sell
2,325
-93
-4% -$14.4K 0.05% 277
2020
Q4 		$377K Sell
2,418
-49
-2% -$6.3K 0.06% 253
2020
Q3 		$283K Sell
2,467
-234
-9% -$25.2K 0.05% 268
2020
Q2 		$304K Sell
2,701
-117
-4% -$12.4K 0.06% 261
2020
Q1 		$253K Buy
+2,818
New +$277K 0.07% 259
2019
Q3 		– Sell
-1,650
Closed -$216K – 365
2019
Q2 		$216K Sell
1,650
-284
-15% -$36.6K 0.05% 334
2019
Q1 		$262K Buy
+1,934
New +$240K 0.07% 329
2018
Q4 		– Sell
-2,109
Closed -$293K – 401
2018
Q3 		$293K Buy
2,109
+161
+8% +$20.2K 0.07% 297
2018
Q2 		$242K Sell
1,948
-107
-5% -$12.5K 0.07% 320
2018
Q1 		$229K Sell
2,055
-428
-17% -$51.2K 0.07% 331
2017
Q4 		$297K Buy
2,483
+85
+4% +$10.4K 0.09% 298
2017
Q3 		$336K Buy
2,398
+123
+5% +$16.7K 0.11% 263
2017
Q2 		$277K Sell
2,275
-154
-6% -$17.9K 0.09% 302
2017
Q1 		$294K Buy
2,429
+210
+9% +$27.1K 0.1% 294
2016
Q4 		$272K Sell
2,219
-382
-15% -$46.7K 0.1% 288
2016
Q3 		$319K Buy
2,601
+71
+3% +$9.14K 0.13% 249
2016
Q2 		$295K Sell
2,530
-2,846
-53% -$404K 0.12% 252
2016
Q1 		$749K Buy
5,376
+429
+9% +$63K 0.27% 123
2015
Q4 		$944K Sell
4,947
-107
-2% -$18.7K 0.36% 93
2015
Q3 		$791K Buy
5,054
+311
+7% +$56.7K 0.3% 103
2015
Q2 		$858K Buy
4,743
+67
+1% +$11.6K 0.3% 104
2015
Q1 		$810K Buy
4,676
+104
+2% +$18.8K 0.29% 110
2014
Q4 		$846K Buy
4,572
+485
+12% +$89.9K 0.32% 98
2014
Q3 		$677K Sell
4,087
-73
-2% -$12K 0.27% 118
2014
Q2 		$650K Sell
4,160
-749
-15% -$118K 0.25% 122
2014
Q1 		$747K Sell
4,909
-21
-0.4% -$3.34K 0.31% 97
2013
Q4 		$655K Buy
4,930
+198
+4% +$23.8K 0.29% 113
2013
Q3 		$550K Sell
4,732
-403
-8% -$44.2K 0.27% 127
2013
Q2 		$474K Buy
+5,135
New +$495K 0.21% 163

Other funds holding ALXN

BCI
Brinker Capital Investments Berwyn, Pennsylvania $11.7B AUM 21.33% 1-Year Est. Return
NICM
Neo Ivy Capital Management New York $379M AUM 28.34% 1-Year Est. Return
TAIM
TD Ameritrade Investment Management Omaha, Nebraska $9.4B AUM 7.2% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $280B AUM 33.63% 1-Year Est. Return
RG
Retirement Group San Diego, California $279M AUM 22.21% 1-Year Est. Return
CFO
CVA Family Office Denver, Colorado $950M AUM 20.72% 1-Year Est. Return
MAM
Meeder Asset Management Dublin, Ohio $1.75B AUM 34.85% 1-Year Est. Return